Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients

Clinical trial NCT07142863 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07142863
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Osteosarcoma Neoadjuvant Therapy Neoadjuvant Chemotherapy PD-L1 Antibody Envafolimab

Start date: 2025-08-25
Primary completion: 2026-08-31
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.